Rosas-Nexticapa Marcela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rosas-Nexticapa Marcela has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Lauro Figueroa-Valverde
Laboratory of Pharmaco-Chemistry at the Faculty of Chemical Biological Sciences of the University Autonomous of Campeche, Av. Agustín Melgar s/n, Col Buenavista, C.P. 24039 Campeche Cam., Mexico
34 shared publications - Magdalena Alvarez-Ramirez
Nutrition Laboratory, Faculty of Nutrition, University of Veracruz, Medicos y s/n Odontologos 910210, Unidad del Bosque, Xalapa, Mexico
20 shared publications - Maria Virginia Mateu-Armad
Universidad Veracruzana
17 shared publications Díaz-Cedillo Francisco
Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional. Prol, Santo Tomas, México
11 shared publications- Enrique Bonilla-Zavaleta
Nutrition Laboratory, Faculty of Nutrition, University of Veracruz, Medicos y s/n Odontologos 910210, Unidad del Bosque, Xalapa, Mexico
10 shared publications García-Cervera Elodia
Laboratory of Pharmaco-Chemistry at the Faculty of Chemical Biological Sciences of the University Autonomous of Campeche, Av. Agustín Melgar s/n, Col Buenavista C.P.24039 Campeche Cam., México
9 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 6 (3) , 32-73
Physico-chemical properties analysis from the docking of some imidazole derivatives with the Ebola-viral matrix protein (VP40)
Ebola is a serious and often fatal viral disease; it is important to mention that some compounds, such as azaguanine-8, favipiravir, and galidesivir, have been used to control this clinical pathology; however, the results are very poor due to their limited effectiveness. This study aimed to determine the docking of imidazole derivatives (1-43) with the VP40 protein involved in the structure of the Ebola virus, using the 5B0V protein as a theoretical tool in the DockingServer program. In addition, imidazole, azagaubine-8, estradiol benzoate, favipiravir, galidesivir, clotrimazole, and L-tetrahydropalmatine were used as controls. The results showed differences in the docking of imidazole derivatives with amino acid residues involved in the 5B0V protein surface compared with the controls. Besides, the Ki values for compounds 23, 24, and 39 were lower compared with the controls. Other data indicate that the Ki values for imidazole derivatives 19 and 42 were lower than those of estradiol benzoate, favipiravir, galidesivir, L-tetrahydropalmatine, and imidazole. Besides, the Ki values for the compounds 3, 17, 19, 21, 34, and 37 were lower in comparison with L-tetrahydropalmatine and imidazole. Finally, the compound's Ki value for 13 was lower compared with imidazole; all this data suggests that compounds 3, 13, 17, 19, 21, 23, 24, 34, 37, 39, and 42 may have a good affinity for the 5B0V protein and could act as VP40 protein inhibitors.
- 18 August 2026
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 6 (3) , 32-73
Open AccessPhysico-chemical properties analysis from the docking of some imidazole derivatives with the Ebola-viral matrix protein (VP40)
Ebola is a serious and often fatal viral disease; it is important to mention that some compounds, such as azaguanine-8, favipiravir, and galidesivir, have been used to control this clinical pathology; however, the results are very poor due to their limited effectiveness. This study aimed to determine the docking of imidazole derivatives (1-43) with the VP40 protein involved in the structure of the Ebola virus, using the 5B0V protein as a theoretical tool in the DockingServer program. In addition, imidazole, azagaubine-8, estradiol benzoate, favipiravir, galidesivir, clotrimazole, and L-tetrahydropalmatine were used as controls. The results showed differences in the docking of imidazole derivatives with amino acid residues involved in the 5B0V protein surface compared with the controls. Besides, the Ki values for compounds 23, 24, and 39 were lower compared with the controls. Other data indicate that the Ki values for imidazole derivatives 19 and 42 were lower than those of estradiol benzoate, favipiravir, galidesivir, L-tetrahydropalmatine, and imidazole. Besides, the Ki values for the compounds 3, 17, 19, 21, 34, and 37 were lower in comparison with L-tetrahydropalmatine and imidazole. Finally, the compound's Ki value for 13 was lower compared with imidazole; all this data suggests that compounds 3, 13, 17, 19, 21, 23, 24, 34, 37, 39, and 42 may have a good affinity for the 5B0V protein and could act as VP40 protein inhibitors.
- Open Access
- 15 August 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (4)
Coupling of Some Fluoride Derivatives to VEGFR-1 and EPHB4 Using a Theoretical Model
Several drugs such as sanguinarine, NVP-VHG712, QDAU5, and VDAU1-11 have been used to treat some cancer cells; however, their interaction with VEGFR-1 AND EPHB4 is not clear. For this reason, in this study, the coupling of some fluoride derivatives (1-36) with VEGFR-1 AND EPHB4 was determined using the 2VWX and 3HNG proteins as theoretical tools. In addition, sanguinarine, NVP-BHG712, QDAU5, and VDAU-11 were used as controls in the DockingServer program. The results showed differences in the number of amino acid residues involved in the coupling of fluoride analogs with the 2VWX and 3HNG proteins compared with the controls. Besides, the fluoride derivatives 6 and 10 have a higher affinity for the 2VWXprotein surface compared to the compounds 1, 3-5, 7-9, and 11-36. Other data indicate that fluorinated analogs 6, 12, 27, and 29 have a higher affinity for the 3HNG protein compared to the compounds 1-5, 7-11, 13-26, and 30-36. In conclusion, these data suggest that the fluorinated derivatives 6, 10, 12, 27, and 29 could act as inhibitors of EGFR-1 and EPHB4. Therefore, these compounds could be good candidates for evaluating their activity in some biological model.
- 15 August 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (4)
Open AccessCoupling of Some Fluoride Derivatives to VEGFR-1 and EPHB4 Using a Theoretical Model
Several drugs such as sanguinarine, NVP-VHG712, QDAU5, and VDAU1-11 have been used to treat some cancer cells; however, their interaction with VEGFR-1 AND EPHB4 is not clear. For this reason, in this study, the coupling of some fluoride derivatives (1-36) with VEGFR-1 AND EPHB4 was determined using the 2VWX and 3HNG proteins as theoretical tools. In addition, sanguinarine, NVP-BHG712, QDAU5, and VDAU-11 were used as controls in the DockingServer program. The results showed differences in the number of amino acid residues involved in the coupling of fluoride analogs with the 2VWX and 3HNG proteins compared with the controls. Besides, the fluoride derivatives 6 and 10 have a higher affinity for the 2VWXprotein surface compared to the compounds 1, 3-5, 7-9, and 11-36. Other data indicate that fluorinated analogs 6, 12, 27, and 29 have a higher affinity for the 3HNG protein compared to the compounds 1-5, 7-11, 13-26, and 30-36. In conclusion, these data suggest that the fluorinated derivatives 6, 10, 12, 27, and 29 could act as inhibitors of EGFR-1 and EPHB4. Therefore, these compounds could be good candidates for evaluating their activity in some biological model.
- Open Access
- 30 July 2026
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 6 (2) , 136-160
Comprehensive bioinformatic analysis identifies some indole derivatives for treating cTnT-associated hypertrophic cardiomyopathy
Alterations in cardiac troponin (cTnT) levels have been observed to be associated with the development of hypertrophic cardiomyopathy. It is worth noting that some drugs have been used to treat hypertrophic cardiomyopathy; however, these drugs act as myosin inhibitors. In the search for a therapeutic alternative for the treatment of this clinical pathology, this study aimed to determine the interaction of some indole derivatives (1-43) with cTnT using the 2n7l protein as a theoretical tool in the DockingServer program. Besides, the compounds indole, bepridil, levosimedam, and DPISTA were used as controls. The results showed differences in the number of amino acid residues involved in the docking of indole derivatives with the 2n7l protein surface compared to the controls. Other results indicate that the Ki values for indole derivatives 2, 4, 11, and 43 were lower compared with compounds 1, 3, 5-10, 12-42, beperidil, indole, and levosimedam. All these data suggest that compounds 2, 4, 11, and 43 may have good affinity for the 2n7l protein surface, which could lead to changes in the biological activity of cTnT. Therefore, these compounds could represent promising candidates for further experimental evaluation using a hypertrophic cardiomyopathy model.
- 30 July 2026
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 6 (2) , 136-160
Open AccessComprehensive bioinformatic analysis identifies some indole derivatives for treating cTnT-associated hypertrophic cardiomyopathy
Alterations in cardiac troponin (cTnT) levels have been observed to be associated with the development of hypertrophic cardiomyopathy. It is worth noting that some drugs have been used to treat hypertrophic cardiomyopathy; however, these drugs act as myosin inhibitors. In the search for a therapeutic alternative for the treatment of this clinical pathology, this study aimed to determine the interaction of some indole derivatives (1-43) with cTnT using the 2n7l protein as a theoretical tool in the DockingServer program. Besides, the compounds indole, bepridil, levosimedam, and DPISTA were used as controls. The results showed differences in the number of amino acid residues involved in the docking of indole derivatives with the 2n7l protein surface compared to the controls. Other results indicate that the Ki values for indole derivatives 2, 4, 11, and 43 were lower compared with compounds 1, 3, 5-10, 12-42, beperidil, indole, and levosimedam. All these data suggest that compounds 2, 4, 11, and 43 may have good affinity for the 2n7l protein surface, which could lead to changes in the biological activity of cTnT. Therefore, these compounds could represent promising candidates for further experimental evaluation using a hypertrophic cardiomyopathy model.
- Open Access
- 15 June 2026
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 5 (8) , 17-37
Comprehensive bioinformatic analysis identifies some alkyne derivatives for treating MYH7-associated hypertrophic cardiomyopathy
Some studies indicate that mutations in the MYH7 gene are associated with hypertrophic cardiomyopathy. It is important to mention that several drugs have been used to treat hypertrophic cardiomyopathy, such as omecamtiv mecarbil, blebbistatin, mavacamten, and aficamten; however, it is necessary to develop a series of drugs that may interact with the MYH7 gene for therapeutic purposes in the treatment of this clinical pathology. For this reason, the aim of this study was to determine the coupling of some alkyne derivatives (1-35) with MYH7 using the 5cj1 protein as a theoretical tool. Besides, omecamtiv mecarbil, blebbistatin, and mavacamten and aficamten drugs were used as controls in the DockingServer program. The results showed differences in the number of aminoacid residues involved in the interaction of alkyne analogues (1-35) with the 5cj1 protein surface compared to the controls. Other data indicate that the inhibition constant (Ki) was higher for alkyne derivatives 7, 12, and 34 compared with the omecamtiv mecarbil, blebbistatin, and mavacamten drugs. However, the Ki for compounds 7, 12, and 34 was lower compared to the alkyne derivatives 1-6, 8-11, 13-33, and 35. These data suggest that compounds 7, 12, and 34 may have good affinity for the 5cj1 protein surface, which could lead to inhibition of the biological activity of MYH7. Therefore, these compounds could represent promising candidates for further experimental evaluation using a hypertrophic cardiomyopathy model.
- 15 June 2026
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 5 (8) , 17-37
Open AccessComprehensive bioinformatic analysis identifies some alkyne derivatives for treating MYH7-associated hypertrophic cardiomyopathy
Some studies indicate that mutations in the MYH7 gene are associated with hypertrophic cardiomyopathy. It is important to mention that several drugs have been used to treat hypertrophic cardiomyopathy, such as omecamtiv mecarbil, blebbistatin, mavacamten, and aficamten; however, it is necessary to develop a series of drugs that may interact with the MYH7 gene for therapeutic purposes in the treatment of this clinical pathology. For this reason, the aim of this study was to determine the coupling of some alkyne derivatives (1-35) with MYH7 using the 5cj1 protein as a theoretical tool. Besides, omecamtiv mecarbil, blebbistatin, and mavacamten and aficamten drugs were used as controls in the DockingServer program. The results showed differences in the number of aminoacid residues involved in the interaction of alkyne analogues (1-35) with the 5cj1 protein surface compared to the controls. Other data indicate that the inhibition constant (Ki) was higher for alkyne derivatives 7, 12, and 34 compared with the omecamtiv mecarbil, blebbistatin, and mavacamten drugs. However, the Ki for compounds 7, 12, and 34 was lower compared to the alkyne derivatives 1-6, 8-11, 13-33, and 35. These data suggest that compounds 7, 12, and 34 may have good affinity for the 5cj1 protein surface, which could lead to inhibition of the biological activity of MYH7. Therefore, these compounds could represent promising candidates for further experimental evaluation using a hypertrophic cardiomyopathy model.
- Open Access
- 15 June 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (3)
Molecular-docking of some Amines and Furane Derivatives with IRAK-4 Using a Theoretical Model
For several years, some IRAK-4 inhibitors have been developed to treat chronic lymphocytic leukemia; however, their interaction with the IRAK-4 kinase is unclear. The aim of this study was to evaluate the interaction of some amine and furanone derivatives with IRAK-4 as a therapeutic alternative to treat chronic lymphocytic leukemia. The theoretical coupling of amine and furanone derivatives with the IRAK-4 was carried out using the 5uit protein as a theoretical model. Besides, 1-439 PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib drugs were used as controls in the DockingServer program. The results displayed different types of amino acid residues involved in the interaction of amine and furanone derivatives with the 5uit protein surface compared to the controls. Besides, the inhibition constant was lower for amino derivatives 3, 9, 25, 33, and 36 compared with the controls. Other data indicate that the inhibition constant was lower for furanone analogs 1, 3, 7, 13, 27, 32, and 34 compared with PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib. In conclusion, theoretical data indicate that amine (3, 9, 25, 33, and 36) and furanones (1, 3, 7, 13, 27, 32, and 34) derivatives might have a higher affinity for the 5uit protein surface compared with the controls. This data suggests that both amino and furanone derivatives can act as IRAK-4 inhibitors, which may serve to treat chronic lymphocytic leukemia.
- 15 June 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (3)
Open AccessMolecular-docking of some Amines and Furane Derivatives with IRAK-4 Using a Theoretical Model
For several years, some IRAK-4 inhibitors have been developed to treat chronic lymphocytic leukemia; however, their interaction with the IRAK-4 kinase is unclear. The aim of this study was to evaluate the interaction of some amine and furanone derivatives with IRAK-4 as a therapeutic alternative to treat chronic lymphocytic leukemia. The theoretical coupling of amine and furanone derivatives with the IRAK-4 was carried out using the 5uit protein as a theoretical model. Besides, 1-439 PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib drugs were used as controls in the DockingServer program. The results displayed different types of amino acid residues involved in the interaction of amine and furanone derivatives with the 5uit protein surface compared to the controls. Besides, the inhibition constant was lower for amino derivatives 3, 9, 25, 33, and 36 compared with the controls. Other data indicate that the inhibition constant was lower for furanone analogs 1, 3, 7, 13, 27, 32, and 34 compared with PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib. In conclusion, theoretical data indicate that amine (3, 9, 25, 33, and 36) and furanones (1, 3, 7, 13, 27, 32, and 34) derivatives might have a higher affinity for the 5uit protein surface compared with the controls. This data suggests that both amino and furanone derivatives can act as IRAK-4 inhibitors, which may serve to treat chronic lymphocytic leukemia.
- 1 May 2026
- Published by Comunicacion Cientifica
- p. 173-183
Estudio de la estabilidad fisicoquímica de microcápsulas de maguey morado obtenidas mediante secado por aspersión
El objetivo de este trabajo fue evaluar y comparar el efecto protector de la maltodextrina 10DE y 20DE sobre el contenido de antioxidantes presentes en el extracto de maguey morado, así como en las microcápsulas obtenidas mediante secado por aspersión y durante el almacenamiento a una temperatura de 25, 35 y 45 °C. Los resultados mostraron que el proceso de secado por aspersión (Tinlet de 130 °C; Toutlet de 80 °C) mejora el grado de protección en el contenido de polifenoles, actividad antioxidante, antocianinas y color, con respecto al extracto puro. Se encontró que los antioxidantes no sufren una degradación significativa en el intervalo de actividad de agua entre 0.1 y 0.4, independientemente de la temperatura de almacenamiento. Por otra parte, la maltodextrina 10DE mostró una mejor protección de los antioxidantes con respecto a la maltodextrina 20DE independientemente de la temperatura de almacenamiento.
- 1 May 2026
- Published by Comunicacion Cientifica
- p. 173-183
Estudio de la estabilidad fisicoquímica de microcápsulas de maguey morado obtenidas mediante secado por aspersión
El objetivo de este trabajo fue evaluar y comparar el efecto protector de la maltodextrina 10DE y 20DE sobre el contenido de antioxidantes presentes en el extracto de maguey morado, así como en las microcápsulas obtenidas mediante secado por aspersión y durante el almacenamiento a una temperatura de 25, 35 y 45 °C. Los resultados mostraron que el proceso de secado por aspersión (Tinlet de 130 °C; Toutlet de 80 °C) mejora el grado de protección en el contenido de polifenoles, actividad antioxidante, antocianinas y color, con respecto al extracto puro. Se encontró que los antioxidantes no sufren una degradación significativa en el intervalo de actividad de agua entre 0.1 y 0.4, independientemente de la temperatura de almacenamiento. Por otra parte, la maltodextrina 10DE mostró una mejor protección de los antioxidantes con respecto a la maltodextrina 20DE independientemente de la temperatura de almacenamiento.
- 1 May 2026
- Published by Comunicacion Cientifica
- p. 119-138
Consumo de tortilla de maíz en población adulta mayor de zona urbana
La población adulta mayor es uno de los grupos de mayor riesgo para presentar problemas nutricionales, tanto por el propio proceso de envejecimiento que causa una menor capacidad de regulación en la ingesta de alimentos, como por otros factores asociados en su contexto de vida. Este estudio tiene como objetivo describir el consumo dietético, preferencias de compra, frecuencia de consumo de tortilla de maíz en personas adultas mayores habitantes de la zona urbana de Xalapa, Veracruz, México; para estimar el aporte nutrimental de la tortilla de maíz en su dieta diaria. En la obtención de la información se aplicó una encuesta de elaboración propia, a una muestra no probabilística por conveniencia de 50 personas, masculinos y femeninos de 60 años de edad en adelante. Se utilizó balanza digital y cinta métrica para medir peso y diámetro de la tortilla. La participación fue voluntaria y bajo consentimiento informado. Para el análisis de datos se utilizó un programa estadístico, para describir los resultados a través de figuras y tablas. Entre los hallazgos encontrados destaca que la población participante sí consume tortillas, en promedio de seis piezas diarias, prefieren las elaboradas con maíz blanco, adquiridas en tiendas y tortillerías tradicionales. Se llegó a la conclusión de que, en México, la tortilla de maíz es parte de la identidad culinaria y se encuentra siempre presente en la dieta diaria de las familias; por lo que presentan apego consolidado hacia su consumo como parte de su dieta cotidiana.
- 1 May 2026
- Published by Comunicacion Cientifica
- p. 119-138
Consumo de tortilla de maíz en población adulta mayor de zona urbana
La población adulta mayor es uno de los grupos de mayor riesgo para presentar problemas nutricionales, tanto por el propio proceso de envejecimiento que causa una menor capacidad de regulación en la ingesta de alimentos, como por otros factores asociados en su contexto de vida. Este estudio tiene como objetivo describir el consumo dietético, preferencias de compra, frecuencia de consumo de tortilla de maíz en personas adultas mayores habitantes de la zona urbana de Xalapa, Veracruz, México; para estimar el aporte nutrimental de la tortilla de maíz en su dieta diaria. En la obtención de la información se aplicó una encuesta de elaboración propia, a una muestra no probabilística por conveniencia de 50 personas, masculinos y femeninos de 60 años de edad en adelante. Se utilizó balanza digital y cinta métrica para medir peso y diámetro de la tortilla. La participación fue voluntaria y bajo consentimiento informado. Para el análisis de datos se utilizó un programa estadístico, para describir los resultados a través de figuras y tablas. Entre los hallazgos encontrados destaca que la población participante sí consume tortillas, en promedio de seis piezas diarias, prefieren las elaboradas con maíz blanco, adquiridas en tiendas y tortillerías tradicionales. Se llegó a la conclusión de que, en México, la tortilla de maíz es parte de la identidad culinaria y se encuentra siempre presente en la dieta diaria de las familias; por lo que presentan apego consolidado hacia su consumo como parte de su dieta cotidiana.
- Open Access
- 12 February 2026
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 5 (3) , 17-30
Intramolecular interaction analysis of forty amine derivatives with phosphodiesterase 4D using a theoretical model
Several drugs, such as zatolmilast, orismilast, lotamilast, and GSK256066 (phosphodiesterase inhibitors) have been used to treat chronic heart failure. However, some of these drugs can produce different secondary effects such as arrhythmia, nausea, and vomiting. In the search for a new therapeutic alternative to treat chronic heart failure, this study aimed to characterize the interaction of some amino derivatives (1-40) with phosphodiesterase 4D using the 3iak protein as a theoretical tool in the DockingServer program. Besides, zatolmilast, orismilast, lotamilast, and GSK256066 were used as controls. The results showed differences in the interaction of amino derivatives with the 3iak protein surface compared with zatolmilast, orismilast, lotamilast, and GSK256066. Other data indicate that the inhibition constant for amino derivatives 7, 12, 15, 18, and 33 was lower compared with the controls. All these data suggest that compounds 7, 12, 15, 18, and 33 could act as phosphodiesterase 4D inhibitors. These data suggest that amino derivatives of phosphodiesterase 4D could be a good therapeutic alternative to treat heart failure.
- 12 February 2026
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 5 (3) , 17-30
Open AccessIntramolecular interaction analysis of forty amine derivatives with phosphodiesterase 4D using a theoretical model
Several drugs, such as zatolmilast, orismilast, lotamilast, and GSK256066 (phosphodiesterase inhibitors) have been used to treat chronic heart failure. However, some of these drugs can produce different secondary effects such as arrhythmia, nausea, and vomiting. In the search for a new therapeutic alternative to treat chronic heart failure, this study aimed to characterize the interaction of some amino derivatives (1-40) with phosphodiesterase 4D using the 3iak protein as a theoretical tool in the DockingServer program. Besides, zatolmilast, orismilast, lotamilast, and GSK256066 were used as controls. The results showed differences in the interaction of amino derivatives with the 3iak protein surface compared with zatolmilast, orismilast, lotamilast, and GSK256066. Other data indicate that the inhibition constant for amino derivatives 7, 12, 15, 18, and 33 was lower compared with the controls. All these data suggest that compounds 7, 12, 15, 18, and 33 could act as phosphodiesterase 4D inhibitors. These data suggest that amino derivatives of phosphodiesterase 4D could be a good therapeutic alternative to treat heart failure.
- 3 February 2026
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 76 (02/03) , 91-98
Intramolecular Interactions of Twenty-Eight Amide Derivatives with the C-ALB Kinase using a Theoretical Model as a Therapeutic Alternative to Treat Cancer
Several studies have shown that some drugs can slow the growth of cancer cells by inhibiting the c-Abl kinase. However, some of these drugs can cause side effects such as gynecomastia, pulmonary toxicity, and lentiginosis, among others. In the search for a therapeutic alternative, some amide derivatives have been developed to treat cancer. However, their interaction with the c-Abl kinase is not clear. The aim of this study was to evaluate the interaction of 28 amide derivatives with the c-Abl kinase as a therapeutic alternative to treat cancer cells. The theoretical interaction of amide derivatives with the c-Abl kinase was carried out using the 1iep protein as a theoretical model. Besides, bosutinib, dasatinib, imatinib, nilotinib, and radotinib were used as controls in the DockingServer program. The results displayed different types of aminoacid residues involved in the interaction of amide derivatives with the 1iep protein surface compared to the controls. In addition, the inhibition constant (Ki) was lower for compounds 15, 16, and 18 compared to radotinib. Finally, the Ki for amide derivatives 1, 19, and 21 were lower compared with bosutinib, dasatinib, imatinib, and nilotinib. Theoretical data indicate that amide derivatives such as 1, 15, 16, 18, 19, and 21 might have a higher affinity for the 1iep protein surface. This phenomenon could be translated as c-Abl kinase inhibition, resulting in a decrease in cancer cell growth.
- 3 February 2026
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 76 (02/03) , 91-98
Intramolecular Interactions of Twenty-Eight Amide Derivatives with the C-ALB Kinase using a Theoretical Model as a Therapeutic Alternative to Treat Cancer
Several studies have shown that some drugs can slow the growth of cancer cells by inhibiting the c-Abl kinase. However, some of these drugs can cause side effects such as gynecomastia, pulmonary toxicity, and lentiginosis, among others. In the search for a therapeutic alternative, some amide derivatives have been developed to treat cancer. However, their interaction with the c-Abl kinase is not clear. The aim of this study was to evaluate the interaction of 28 amide derivatives with the c-Abl kinase as a therapeutic alternative to treat cancer cells. The theoretical interaction of amide derivatives with the c-Abl kinase was carried out using the 1iep protein as a theoretical model. Besides, bosutinib, dasatinib, imatinib, nilotinib, and radotinib were used as controls in the DockingServer program. The results displayed different types of aminoacid residues involved in the interaction of amide derivatives with the 1iep protein surface compared to the controls. In addition, the inhibition constant (Ki) was lower for compounds 15, 16, and 18 compared to radotinib. Finally, the Ki for amide derivatives 1, 19, and 21 were lower compared with bosutinib, dasatinib, imatinib, and nilotinib. Theoretical data indicate that amide derivatives such as 1, 15, 16, 18, 19, and 21 might have a higher affinity for the 1iep protein surface. This phenomenon could be translated as c-Abl kinase inhibition, resulting in a decrease in cancer cell growth.
- Open Access
- 5 November 2025
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 4 (12) , 44-55
Analysis of the coupling of twenty-five benzothiazole analogs with the β1-adrenergic receptor using a theoretical model
Some benzothiazoles have been developed with biological activity on the cardiovascular system through interaction with different biomolecules; however, the coupling with the β1-adrenergic receptor is not clear. This research aimed to determine the interaction of some benzothiazole analogs (1-25) with the β1-adrenergic receptor using some theoretical models. In this way, 2ycv protein and the controls (metoprolol, propranolol, and cyanopindolol) were used as theoretical tools in the DockingServer software. The results showed differences in the interaction of benzothiazole derivatives compared with the controls. Other data indicate that the inhibition constant (Ki) for benzothiazole analogs 10, 22, 23, and 25 was lower compared with metoprolol and cyanopindolol. All these data indicate that compounds 10, 22, 23, and 25 may act as β1-adrenergic receptor inhibitors, translated into changes in blood pressure. Therefore, the benzothiazole derivatives 10, 22, 23, and 25 could be good antihypertensive agents.
- 5 November 2025
- Published by Lepidus Tecnologia in Brazilian Journal of Science
- Vol. 4 (12) , 44-55
Open AccessAnalysis of the coupling of twenty-five benzothiazole analogs with the β1-adrenergic receptor using a theoretical model
Some benzothiazoles have been developed with biological activity on the cardiovascular system through interaction with different biomolecules; however, the coupling with the β1-adrenergic receptor is not clear. This research aimed to determine the interaction of some benzothiazole analogs (1-25) with the β1-adrenergic receptor using some theoretical models. In this way, 2ycv protein and the controls (metoprolol, propranolol, and cyanopindolol) were used as theoretical tools in the DockingServer software. The results showed differences in the interaction of benzothiazole derivatives compared with the controls. Other data indicate that the inhibition constant (Ki) for benzothiazole analogs 10, 22, 23, and 25 was lower compared with metoprolol and cyanopindolol. All these data indicate that compounds 10, 22, 23, and 25 may act as β1-adrenergic receptor inhibitors, translated into changes in blood pressure. Therefore, the benzothiazole derivatives 10, 22, 23, and 25 could be good antihypertensive agents.